About
Jae Kim is an associate in DLA Piper's FDA Regulatory Group, advising clients in the life sciences, food and beverage, hemp and CBD, and consumer products industries on regulatory compliance and risk management matters before FDA, USDA, TTB, DEA, FTC, and state authorities. Her practice covers medical devices, drugs, dietary supplements, food and beverage, alcohol, hemp and CBD products, and cosmetics, including product development, approval strategy, cGMPs, licensing, labeling, advertising, inspections, recalls, and regulatory enforcement actions. She also handles regulatory due diligence for acquisitions and strategic advice in investigations, litigation, and arbitrations.
Practice areas
FDA RegulatoryLitigationArbitration and InvestigationsProduct LiabilityMass TortsProduct StewardshipRegulatory and Government AffairsLife SciencesHealthcare
Office
Expertise
FDA Regulatory ComplianceLife SciencesFood and BeverageHemp and CBDConsumer ProductsMedical DevicesDrugs (Prescription and OTC)Dietary SupplementsAlcoholCosmeticsRegulatory Due DiligenceInternal InvestigationsLitigation and Arbitration SupportCOVID-19 Regulatory RequirementsEmergency Use Authorization (EUA)
Education
- J.D., University of Notre Dame Law School
- B.A., Johns Hopkins University
Languages
EnglishKorean